Organon & Co.
OGN
Market Cap$2.59B
Close$
$28.33
191.5% upside
Current Fair Value
191.5% upsideUndervalued by 191.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.59 Billion |
|---|---|
| Enterprise Value | $2.60 Billion |
| Dividend Yield | $0.86 (8.634538152610439%) |
| Earnings per Share | $3.36 |
| Beta | 0.55 |
| Outstanding Shares | 257,862,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 3.42 |
|---|---|
| PEG | -6.04 |
| Price to Sales | 0.41 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | 2.05 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 16.85 |
Revenue Sources
No data
Insider Trades
ESG Score
No data